Characterization of Infant Spinal Anesthesia Using Surface Electromyography: An Observational Study
Samuel J Aldous BS, Dylan T Casey BS, Michael DeSarno MS, Emmett E Whitaker MD, FAAP
“Historically, the clinical characteristics of these anesthetic techniques have been described subjectively, and no study has objectively characterized infant Spinal anesthesia (SA) versus caudal epidural anesthesia (CEA). Surface electromyography (sEMG) is a safe, inexpensive, and non-invasive method to study the behavior of neural blockade. The goal of this observational study was to objectively define the rate of onset, maximum effect, and duration of infant SA versus CEA using continuous sEMG.”
Published in Pediatric Anesthesia, October 2023
presentations at:
International Anesthesia Society of Research Annual Meeting, Denver, CO April 13-14, 2023
Association of University Anesthesiologists Annual Meeting, Denver, CO, April 14-16, 2023
August 23, 2023
Baltimore Tech Council
BLOCKsynop was a highlighted startup at the August Meet the Member event for the Maryland Tech Council. Thank you to our friends at Root3 Labs of Owings Mills for hosting this event and to the folks from the MTC’s Baltimore Regional Tech Charter for organizing. BLOCKsynop had a great time showcasing the Neural Blockade Monitor, networking, and making new friends. (continue reading)
April 2023
Happy Anniversary to BLOCKsynop – 3 years.
February 10, 2023
BLOCKsynop, Inc. Awarded National Science Foundation SBIR Grant
BLOCKsynop, Inc. has been awarded $275,000 for a highly selective Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The NSF selects SBIR grant recipients with promising technologies to help jump start their entrepreneurial journey. This grant will be used to accelerate development and commercialization of the Neural Blockade Monitor (NBM). (continue reading)
February 8, 2023
BLOCKsynop invited to the TEDCO MII Pop-up with the HMJ Foundation –
BLOCKsynop was one of ten Maryland Technology Development Corporation {TEDCO} companies invited to exhibit and pitch during the Maryland Innovation Initiative (MII) Pop-up to celebrate the new collaboration between TEDCO’s MII and The Henry M. Jackson Foundation for the Advancement of Military Medicine. (continue reading)
January 25, 2023
BLOCKsynop presents at MTC Pitch and Pour
The Maryland Tech Council, the Baltimore Regional Tech Council and TEDCO invited BLOCKsynop to present at their Pitch & Pour event. It was a unique way to connect people and start conversations between attendees and technology companies. The BLOCKsynop team met fascinating people and answered intriguing questions about the Neural Blockade Monitor. (continue reading)
March 3, 2022
BLOCKsynop selected for TEDCO Proposal Lab
Maryland Technology Development Corporation {TEDCO} announced today the selection of 26 Maryland companies to participate in its FY2022 SBIR/STTR Proposal Lab cohort, now in its fourth year. The companies will work closely with TEDCO experts on preparing polished proposals for up to $275,000 in federal awards through the SBIR/STTR Phase 1 program. The 26 companies in this year’s cohort conduct cutting-edge research in a variety of disciplines, from medical devices to learning and cognition technologies—and even edible bugs! (continue reading)
October 23, 2020
BLOCKsynop receives TEDCO MII grant
TEDCO, Maryland’s economic engine for technology companies, announced its recent round of funding, including investments in 12 start-up companies and funding to 36 university projects through the Maryland innovation Initiative (MII) (continue reading)
October 6, 2020
Johns Hopkins APL Signs Licensing Agreement with Sternberger’s BLOCKsynop
When Wayne Sternberger received the inaugural “Archimedes Award” through the Johns Hopkins Applied Physics Laboratory’s Entrepreneurial & Staff Alumni Program (AeSAP) in February, he was ready to run with the award offerings — two years of office and lab space in Johns Hopkins Technology Ventures’ (JHTV) FastForward innovation hubs, access to JHTV’s resources and APL benefits — to commercialize his neural blockade monitor. (continue reading)